2022 Autonomic Disorders Reading List, Learning Objectives, and CME

Reading List

Please click below to access the 2022 Autonomic Disorders reading list.

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

• Facilitate accurate diagnosis of patients with autonomic dysfunction, including autonomic failure, disorders of orthostatic tolerance, and syncope
• Correctly incorporate treatment modalities in the patient population that is most likely to benefit from them, including disorders of orthostatic tachycardia, orthostatic hypotension, and syncope
• Utilize testing modalities to better characterize and understand the pathophysiology of autonomic disorders

Core Competencies

• Medical Knowledge

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within 24 hours of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 15 AMA PRA Category 1^TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry & Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved the program as a part of a comprehensive self-assessment (SA) program, which is mandates by the American Board of Medical Specialties as a necessary component of maintenance of certification. The number of ABPN SA credits granted will equal the number of CME hours claimed for the activity. 

Disclosures

The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy. 

2022 C-cert Activity Planner Disclosures
All relevant financial relationships have been mitigated.

Autonomic Disorders Certification Examination Committee Contributors

Elizabeth Coon, MD, Mayo Clinic – Rochester 
Disclosures: Nothing to disclose.

Satish Raj, MD, Vice Chair, University of Calgary
Disclosures: Received personal fees and non-financial support from Lundbeck LLC (consulting); received personal fees from the following: Theravance Biopharma US (consulting), Arena Pharmaceuticals (DSMB Chair), Academy for Continued Healthcare Learning (development of neurogenic orthostatic hypotension CME teaching materials), Spire Learning (development of neurogenic orthostatic hypotension CME teaching materials), and Medscape LLC (development of neurogenic orthostatic hypotension CME teaching materials). Received research enrolment fees (to University of Calgary) from Medtronic Inc and Abbott Laboratories.

Srikanth Muppidi, MD, Stanford Neuroscience Health Center
Disclosures: Received personal compensation from Alexion, Argenx, and ucb/ra pharma. 

Brian Olshansky, MD, University of Iowa Hospitals and Clinics
Disclosures: Received personal compensation from Amarin - REDUCE-IT DSMB (consultant), Boehringer Ingelheim - GLORIA AF trial; Sanofi Aventis (consultant), Artivion (consultant), AstraZeneca - DIALIZE-O DSMB, and Lundbeck (speaker and consultant). Member of International Board of Heart Rhythm Examiners (IBHRE) exam committee.

Lauren Phillips, MD, UT Southwestern Medical School
Disclosures: Nothing to disclose.

Cyndya A. Shibao, MD, MSCI, Vanderbilt University Medical Center
Disclosures: Received personal compensation from Theravance Biopharma, research support from Theravance Biopharma, and compensation/research funding from government organization.

Howard Snapper, MD, WellStar Medical Group
Disclosures: Received speaker fees from Akcea and Lundbeck.

Kamal Shouman, MD, Mayo Clinic – Rochester 
Disclosures: Nothing to disclose.

Amanda Peltier, MD, Vanderbilt University Medical Center
Disclosures: Received consulting/speaker fees from CSL Behring (investigator-initiated grant applied funding), Catalyst, Alnylam, and Ionis; CSL grant research funding being negotiated. Serves on the ABPN Neuromuscular Exam Committee.

Gisela G. Chelimsky, MD, Virginia Commonwealth University
Disclosures: Received compensation for legal consultation

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326